William Rice
Chief Executive Officer bij APTOSE BIOSCIENCES INC.
Vermogen: 56 799 $ op 31-03-2024
Profiel
William G.
Rice is the founder of Achillion Pharmaceuticals, Inc., which was founded in 1998.
He held the title of President, Chief Executive Officer & Director from 1998 to 2003.
Dr. Rice's current job(s) include being the Chairman, President, CEO & CAO at Aptose Biosciences, Inc. since 2013 and the Chairman at Cylene Pharmaceuticals, Inc. since 2003.
His former job(s) include serving as an Independent Director at Oncolytics Biotech, Inc. from 2015 to 2021, being a Member-Pediatric Hematology & Oncology at Emory University School of Medicine from 1989 to 1992, and working as a Senior Scientist & Head-Drug Mechanism Lab at Frederick National Laboratory For Cancer Research from 1992 to 1998.
Dr. Rice obtained his doctorate degree from Emory University in 1986.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
APTOSE BIOSCIENCES INC.
0.22% | 05-02-2024 | 34 216 ( 0.22% ) | 56 799 $ | 31-03-2024 |
Actieve functies van William Rice
| Bedrijven | Functie | Begin |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Chief Executive Officer | 28-10-2013 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Chairman | 28-09-2010 |
Eerdere bekende functies van William Rice
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 01-01-2021 |
| ACHILLION PHARMACEUTICALS, INC. | Founder | 01-08-2003 |
| Frederick National Laboratory For Cancer Research | Corporate Officer/Principal | 01-01-1998 |
| Emory University School of Medicine | Corporate Officer/Principal | 01-01-1992 |
Opleiding van William Rice
| Emory University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
| Frederick National Laboratory For Cancer Research |
